Previous studies evaluating the prognostic value of FOLR1 expression in ovarian cancer have reported conflicting results [7,8,14,15], probably due to heterogeneity in methodology and the lack of inclusion of all known prognostic factors in the multivariate analyses. This evidence concerns the gene FOLR1 and ovarian carcinoma.